ReviewJournal of diabetes and metabolic disorders2024
Omics experiments in Iran, a review in endocrine and metabolism disorders studies.
Review in Journal of diabetes and metabolic disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Transforming Cancer Care: Genomic Profiling, AI, and Next-Generation Drug Delivery Systems.Current genomics · 2025Review
- Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview.Journal of diabetes and metabolic disorders · 2022Review
- Circulating amino acids and acylcarnitines correlated with different CAC score ranges in diabetic postmenopausal women using LC-MS/MS based metabolomics approach.BMC endocrine disorders · 2022Article
- Machine Learning: A New Prospect in Multi-Omics Data Analysis of Cancer.Frontiers in genetics · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study was to evaluate the status of scientific research output of omics in regards to human diseases with more attention shifted toward endocrine and metabolism disorders in Iran, in order to find scientific gaps and also to design future plans for further investigations in this field. Methods: Extensive search was performed in the electronic databases of Scopus and PubMed, and documents published by Iranian authors up to 27 December 2020 were extracted. Articles related to human diseases were included and categorized based on their types and topics. Results: A total of 904 publications were found. Followed by checking their titles and abstracts, 327 studies were included. The trend of publication has been increasing during the past years. Regarding this subject, the highest number of publications was in the field of malignant disorders with 82 publications followed by reproductive system diseases and infectious diseases with 33 publications in each subject. Only 12 articles were found in the field of endocrinology and metabolism. The most popular techniques used in those reports were two-dimensional electrophoresis coupled with mass spectrometry (34.4 %) followed by NMR (22.6 %), LC/MS/MS (15 %). Conclusions: Omics studies in Iran are a relatively new approach and the number of original articles regarding endocrine disorders in humans is limited. Providing appropriate infrastructures including lab facilities with high technology instruments can improve the quality and quantity of basic and clinical researches in this field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.